Probiotic (VSL 3) for Gulf War Illness
Technical Report,08 Sep 2014,07 Sep 2015
Western Institute for Biomedical Research Salt Lake City United States
Pagination or Media Count:
The overall objective of the study is to determine whether probiotic VSL3 will improve 1 intestinal symptoms of Irritable Bowel Syndrome and 2 non-intestinal symptoms fatigue, joint pain, insomnia, general stiffness and headache associated with IBS. All of these symptoms are part of the Gulf War illness. We screened our first participant in September 2013. Overall we have screened 65 and 30 randomized and 9 Gulf War Veterans are waiting for arrival of study drug. Our efforts are ongoing to recruit more Gulf War veterans. The first batch of stool samples have been sent to Lawrence Berkeley Laboratory microbiota analysis.